Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin

BACKGROUND: We compared the efficacies of vildagliptin (50 mg twice daily) relative to pioglitazone (15 mg once daily) as an add-on treatment to metformin for reducing glycosylated hemoglobin (HbA1c) levels in Korean patients with type 2 diabetes. METHODS: The present study was a multicenter, random...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Diabetes Metab J
Autori principali: Kim, Jong Ho, Kim, Sang Soo, Baek, Hong Sun, Lee, In Kyu, Chung, Dong Jin, Sohn, Ho Sang, Bae, Hak Yeon, Kim, Mi Kyung, Park, Jeong Hyun, Choi, Young Sik, Kim, Young Il, Hahm, Jong Ryeal, Lee, Chang Won, Jo, Sung Rae, Park, Mi Kyung, Lee, Kwang Jae, Kim, In Joo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Diabetes Association 2016
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4929227/
https://ncbi.nlm.nih.gov/pubmed/27098505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2016.40.3.230
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi